AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore

Geisinger at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Geisinger brings 2 presentations to AMP 2026 in Seattle. Its sessions cover molecular diagnostics for pancreatic lesions, and how testing sharpens care for patients whose disease is hard to see. It also joins a listening session on artificial intelligence in molecular pathology.

OrganizationAMP 2026 Attendance
Geisinger
Danville, PA
Med centres
Health system in central Pennsylvania that runs the MyCode population genomic screening programme alongside its hospitals and clinics.
Workshop
Thu, Nov 12
3:45pm–4:15pm
AI in Molecular Pathology: Your Voice, Our Future
A listening session where attendees help shape AMP's AI position statement on responsible use, workforce, data, regulation and reimbursement.
Workshop
Thu, Nov 12
4:25pm–4:55pm
It's Hard to Treat What You Can't See: Leveraging Molecular Diagnostics to Improve Care of Patients with Pancreatic Lesions
Pancreatic lesions are hard to call on imaging and cytology alone; molecular testing can sharpen diagnosis and risk stratification.
Workshop hosted by Thermo Fisher Scientific

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Geisinger

Tell us what you sell and we’ll find the people at Geisinger most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction